share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

辉瑞 | 4：持股变动声明-董事 SMITH JAMES C
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心信息
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
最近，辉瑞报告人詹姆斯·C·史密斯（James C. Smith）于2024年6月28日进行了股票交易。 交易的详细信息，包括交易股数、股票性质、交易价格和股票总价值，在公告中未予披露。詹姆斯·C·史密斯与辉瑞之间的关系未被指定，并且交易后史密斯持有的股票数量仍未公开。
最近，辉瑞报告人詹姆斯·C·史密斯（James C. Smith）于2024年6月28日进行了股票交易。 交易的详细信息，包括交易股数、股票性质、交易价格和股票总价值，在公告中未予披露。詹姆斯·C·史密斯与辉瑞之间的关系未被指定，并且交易后史密斯持有的股票数量仍未公开。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息